Outsourcing Innovation eBook February 2024
Read the article: A Closer Look at Affinity Ligands
Read the eBook: Pharmaceutical Technology/Pharmaceutical Technology Europe Outsourcing Innovation eBook February 2024
A Closer Look at Affinity Ligands
Feature
Article
Pharmaceutical TechnologyBio/Pharma Outsourcing Innovation, February 2024 eBook
Volume 2024 eBook
Issue 2
Pages: 16-21
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
Graphene water filter, 3D illustration | Image Credit: © Dr_Microbe - stock.adobe.com; doctor analyzes monoclonal antibodies | Image Credit: © Paulista - stock.adobe.com; Final image by Maria Xelo
Affinity ligands play an exciting role in the ever-growing sphere of downstream processing. In speaking with Pharmaceutical Technology®, Phillip Elliott, PhD, associate director of Process Development, BioCina; Jan Bekker, PhD, director, Business Development, Commercial and Technical Operations, BioCina; and Parviz Shamlou, PhD, senior vice-president of Science & Technology, Abzena illuminate the newest innovations with affinity ligands and provide a deeper understanding of the role affinity ligands play in the future of downstream processing.
Read this article in Pharmaceutical Technology’s Bio/Pharma Outsourcing Innovation eBook.
About the author
Daria Husni is assistant editor to Pharmaceutical Technology® and Pharmaceutical Technology Europe®.
Article details
Pharmaceutical Technology/Pharmaceutical Technology Europe Outsourcing Innovation eBook
Issue 2
February 2024
Pages: 16-21
Citation
When referring to this article, please cite it as Husni, D. A Closer Look at Affinity Ligands. Pharmaceutical Technology, Bio/Pharma Outsourcing Innovation eBook. February 2024.
Recent Videos
Related Content
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025Article
The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024Podcast
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
